BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20091941)

  • 21. Prospects for use of a varicella vaccine in adults.
    Hardy IR; Gershon AA
    Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology of Varicella Immunization in the elderly.
    Raeder CK; Hayney MS
    Ann Pharmacother; 2000 Feb; 34(2):228-34. PubMed ID: 10676831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
    Chaves Tdo S; Lopes MH; de Souza VA; Dos Santos Sde S; Pereira LM; Reis AD; David-Neto E
    Pediatr Transplant; 2005 Apr; 9(2):192-6. PubMed ID: 15787792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live virus immunization after orthotopic liver transplantation.
    Khan S; Erlichman J; Rand EB
    Pediatr Transplant; 2006 Feb; 10(1):78-82. PubMed ID: 16499592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.
    Almuneef M; Dillon J; Abbas MF; Memish Z
    Am J Infect Control; 2003 Oct; 31(6):375-81. PubMed ID: 14608306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Varicella vaccination].
    Heidl M; Scholz H
    Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status of live attenuated varicella vaccine.
    Gershon AA
    Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Gershon AA; Steinberg SP
    J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
    Gelb LD; Dohner DE; Gershon AA; Steinberg SP; Waner JL; Takahashi M; Dennehy PH; Brown AE
    J Infect Dis; 1987 Apr; 155(4):633-40. PubMed ID: 3029239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early experience with varicella vaccination in pediatric heart transplant recipients.
    Dipchand AI; Seifert-Hansen M
    J Heart Lung Transplant; 2022 Aug; 41(8):1023-1026. PubMed ID: 35279390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live varicella immunization in healthy non-immune nurses.
    Ndumbe PM; Cradock-Watson JE; Heath RB; Levinsky RJ
    Postgrad Med J; 1985; 61 Suppl 4():133-5. PubMed ID: 3014470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
    Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
    Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.